跳至主要内容
临床试验/NL-OMON41509
NL-OMON41509已完成不适用

The effect of TNFa-blockers on B-cells in patients with granulomatous diseases. - TNFa-blockers and B-cells in granulomatous diseases.

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age > 18 years
  • Biopsy proven sytemic granulomatous disease as Crohn's Disease/Sarcoidosis
  • Intention to start treatment with TNFa-blockers; infliximab

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
不适用
Estudio de los efectos de la terapia anti-célula B (rituximab) sobre la inmunopatología del tejido sinovial y las células B de sangre periférica en artritis reumatoide (Estudio TESICE-AR).Study of the B-cell-targeted therapy (rituximab) effects on the synovial tissue inmunopathology and peripheral blood B cells in rheumatoid arthritis (TESICE-AR study).Se estudiaran los efectos de la terapia anti-célula B (rituximab) sobre la inmunopatología del tejido sinovial y las células B de sangre periférica en artritis reumatoide.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritis
EUCTR2007-003623-20-ESDr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona
进行中(未招募)
1 期
T cells and TNF: The impct of TNF blockade on effector T cell populations in rheumatoid arthritis and other conditions treated with anti-TNF-alpha agents. - T cells and TNFRheumatoid arthritis Psoriatic arthritis Ankylosing spondylitisMedDRA version: 12.0 Level: LLT Classification code 10039073 Term: Rheumatoid arthritisMedDRA version: 12.0 Level: LLT Classification code 10037160 Term: Psoriatic arthritisMedDRA version: 12.0 Level: LLT Classification code 10002556 Term: Ankylosing spondylitis
EUCTR2009-012424-87-GBImperial College London South Kensington London55
进行中(未招募)
1 期
Effectiveness of anti TNFalpha agents in Behcet¿s diseaseBEH¿ET¿S DISEASE REFRACTORY TO STANDARD OF CARE THERAPIESMedDRA version: 20.0Level: LLTClassification code 10004215Term: Behcets diseaseSystem Organ Class: 100000004866
EUCTR2017-000845-39-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA46
已完成
2 期
Effect of Infliximab on treatment of cirrhosis.Cryptogenic cirrhosis.Other and unspecified cirrhosis of liver
IRCT2016052228003N1Research center for infectious diseases of digestive system, research adjutancy of Ahvaz Jundishapur30
已完成
不适用
Effect of anti-tumour necrosis factor alpha (TNFa) therapy on blood vessel health in patients with rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisRheumatoid arthritis
ISRCTN57761809niversity of Dundee (UK)90